At a glance
ClinicalIndex Comparison RecordN/ACompleted· 7,729 enrolled
Drug / intervention
75g oral glucose tolerance test (OGTT)other
Likely dose
75g oral glucose tolerance test (OGTT)from record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Maternal TSH Level and TPOAb Status in Early Pregnancy and Their Relationship to the Risk of Gestational Diabetes Mellitus
In Brief
An observational study evaluating 75g oral glucose tolerance test (OGTT) for Pregnancy and 2 related conditions. Completed, enrolled 7,729 participants.
Detailed Summary
This study was conducted to analyze the role of TSH level and TPOAb status in early pregnancy and use this information in assessment of the risk of gestational diabetes mellitus at different weeks of gestation when the FT4 level is normal.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2012
Primary CompletionMar 2014
First PostedSep 2015
TodayJul 2026
First PostedSep 21, 2015
Enrollment StartDec 1, 2012
Primary CompletionMar 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 10.8 years ago
Interventions
75g oral glucose tolerance test (OGTT)other
All these women underwent the 75g oral glucose tolerance test (OGTT) at 24-28 weeks of gestation.